Reduction in the rate of EGFR decline with semaglutide vs placebo: a post hoc pooled analysis of SUSTAIN 6 and PIONEER 6

Citation
Tuttle K, Cherney D, Hadjadj S, et al. Nephrol Dial Transpl 2020;35(Suppl 3):gfaa141.TO002.